Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“In evidence based medicine, ‘discordance’ is when recommendations don’t align with evidence, either in strength or direction
Co-authors Jeremy Jacobs, et al examined discordance in the American Society for Apheresis guidelines, widely used to justify which patients should get exchange transfusions. The thrust of our argument is that although some discordance is expected in clinical areas dealing with clinical areas where it is harder to perform large studies (e.g. rare diseases), each instance should be transparently acknowledged and justified to highlight knowledge gaps and uncertainty.”
Title: When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis Guidelines
Authors: Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins, Victoria Costa, Sheharyar Raza, Yara A. Park, Joseph Yossi Schwartz, Evan M. Bloch
Read the Full Article on Journal of Clinical Apheresis

More posts featuring Sheharyar Raza on Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM